Melanotan II

Name: Melanotan II
Brand: LORIUM
SKU: melanotan-ii
Availability: InStock

Melanocortin agonist · MT-II

Melanotan II is an advanced cyclic α-MSH analogue engineered as a non-selective melanocortin receptor agonist to drive both structural and metabolic rejuvenation. By crossing the blood-brain barrier to target hypothalamic centers while simultaneously activating dermal receptors, this dual-action protocol uniquely stimulates natural skin pigmentation alongside robust metabolic and libido optimization.

$89 / month · 5 mg

Request through a provider Start intake to prescribe

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. It is dispensed only pursuant to a valid prescription following evaluation by a licensed provider.

Researched effects

Effects observed in the cited literature. Individual results are not guaranteed. Statements have not been evaluated by the FDA.

Accelerated Deep Tanning

Promotes rapid, uniform skin darkening with minimal to zero UV exposure.

Advanced Appetite Suppression

Effectively modulates hypothalamic signaling to reduce caloric intake.

Optimized Body Composition

Supports accelerated fat loss while fully preserving lean muscle mass.

Dermal Melanogenesis

Activates MC1R to promote deep tanning without UV exposure.

Targeted Erectile Support

Studied to show structural efficacy in inducing performance erections.

Amplified Baseline Libido

Powerfully boosts intrinsic sexual desire and arousal in men and women.

Glycemic Equilibrium

Improves systemic glucose metabolism and cellular insulin sensitivity.

Specifications

ClassMelanocortin agonist

CAS number121062-08-6

Molar mass1024.18 g/mol

Available sizes5 mg

AdministrationPremium subcutaneous optimization protocol.

CategoryVitality

View a sample certificate of analysis →

Clinical references

Dorr, R. T., et al. (1996). Evaluation of Melanotan-II for Skin Pigmentation. Life Sciences, 58(20).
Wessells, H., et al. (1998). Effect of Melanotan II on Erectile Function. Journal of Urology, 160(2).
Wessells, H., et al. (2000). Melanocortin Receptor Agonists and Sexual Arousal. Int J Impotence Res, 12(4).
Strader, A. D., et al. (2007). Metabolic Influences of Central Melanocortin Activation. J Pharmacol Exp Ther, 322(3).